[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"nausea-and-vomiting-induced-by-antibody-drug-conjugates-adcs\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:nausea-and-vomiting-induced-by-antibody-drug-conjugates-adcs":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100646423","phase-2-fosrolapitant-and-palonosetron-for-the-prevention-of-antibody-drug-conjugate-induced-nausea-and-vomiting-100646423",false,"NCT07692451","Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting","A Randomized Controlled Study of Fosrolapitant and Palonosetron for the Prevention of Nausea and Vomiting Induced by Antibody-Drug Conjugates in Cancer Patients","Inclusion Criteria:\n\n\\-\n\nExclusion Criteria:\n\n1. 18 years of age or older, of either gender\n2. Has a diagnosed malignant tumor\n3. has never been treated with ADCs and is to receive the first course of ADCs\n4. Predicted life expectancy of ≥ 3 months\n5. Has a performance status (ECOG scale) of 0 to 1\n6. Adequate bone marrow, kidney, and liver function\n7. Women of childbearing potential must have negative pregnancy test (serum test) results within 72 hours prior to enrollment\n8. Able and willing to provide a written informed consent","ALL","18 Years",{"count":19,"type":20},124,"ESTIMATED","INTERVENTIONAL",[23],"PHASE2","This study is aimed to evaluate the efficacy and safety of Fosrolapitant and Palonosetron for Antibody-drug conjugate-induced nausea and vomiting",[26],"Nausea and Vomiting Induced by Antibody-drug Conjugates (ADCs)","NOT_YET_RECRUITING","2026-07-03",{"date":30,"type":31},"2026-07-09","ACTUAL",{"date":33,"type":20},"2026-07-15",{"date":35,"type":20},"2027-09-30",{"name":37,"class":38},"Peking University Cancer Hospital & Institute","OTHER"]